The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

By Tarun Sai Lomte Groundbreaking study reveals new single-chain mRNA vaccines provide 100% protection against lethal mpox ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

On Monday, Moderna Inc (MRNA) stock saw a decline, ending the day at $53.8 which represents a decrease of $-0.30 or -0.55% from the prior close of $54.1. The stock opened at $53.82 and touched a low ...

Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.

The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...

Messenger RNA (mRNA) serves as a blueprint for proteins. When mRNA is no longer needed, it must be degraded. Director Elena ...